DAVID JOPKE: Open Payments
NPI 1881372472 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,599 in 73 payments from 24 companies in 2025. Trend: 2023 $153 · 2024 $2,787 · 2025 $5,599
Speaker / faculty: $3,200Food & beverage: $1,992Travel & lodging: $407
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 8 | $3,413 |
| Medtronic, Inc. | 6 | $549 |
| Dexcom, Inc. | 10 | $384 |
| Novo Nordisk Inc | 15 | $324 |
| Abbott Laboratories | 4 | $178 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $151 |
| Sequel Med Tech, LLC | 1 | $79 |
| Mannkind Corporation | 3 | $76 |
| Almatica Pharma LLC | 4 | $63 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
Products named: OMNIPOD, MINIMED 780G, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, Ozempic, Kerendia, DEXCOM G7 GSS (161), Wegovy.
Industry payments across AZ — which companies pay providers there.
